University of Glasgow: New treatment significantly lowers the risk of cardiovascular death in patients with heart failure
August 30, 2022
August 30, 2022
GLASGOW, Scotland, Aug. 30 (TNSjou) -- The University of Glasgow issued the following news:
A medication, commonly used for the treatment of type 2 diabetes, has been found to significantly lower the risk of cardiovascular death in patients with heart failure. A team of international researchers also found that the same drug was able to reduce worsening heart failure.
Two linked studies, published in the New England Journal of Medicine and Nature Medicine, and delivered . . .
A medication, commonly used for the treatment of type 2 diabetes, has been found to significantly lower the risk of cardiovascular death in patients with heart failure. A team of international researchers also found that the same drug was able to reduce worsening heart failure.
Two linked studies, published in the New England Journal of Medicine and Nature Medicine, and delivered . . .